nodes	percent_of_prediction	percent_of_DWPC	metapath
Tramadol—SLC6A4—conduct disorder	0.966	1	CbGaD
Tramadol—Venlafaxine—SLC6A4—conduct disorder	0.00497	0.695	CrCbGaD
Tramadol—SLC6A2—autonomic nervous system—conduct disorder	0.00226	0.429	CbGeAlD
Tramadol—Dextromethorphan—SLC6A4—conduct disorder	0.00218	0.305	CrCbGaD
Tramadol—SLC6A4—Serotonin Transporter Activity—MAOA—conduct disorder	0.00194	0.0888	CbGpPWpGaD
Tramadol—HTR2C—Serotonin receptors—HTR2A—conduct disorder	0.00102	0.0468	CbGpPWpGaD
Tramadol—SLC6A2—Monoamine Transport—SLC6A4—conduct disorder	0.000945	0.0432	CbGpPWpGaD
Tramadol—HTR2C—Monoamine GPCRs—DRD4—conduct disorder	0.000699	0.0319	CbGpPWpGaD
Tramadol—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—conduct disorder	0.000681	0.0311	CbGpPWpGaD
Tramadol—GRIN3A—brain—conduct disorder	0.000621	0.118	CbGeAlD
Tramadol—CHRM3—Monoamine GPCRs—DRD4—conduct disorder	0.000602	0.0275	CbGpPWpGaD
Tramadol—HTR2C—Amine ligand-binding receptors—DRD4—conduct disorder	0.000587	0.0268	CbGpPWpGaD
Tramadol—CHRM3—Amine ligand-binding receptors—DRD4—conduct disorder	0.000506	0.0231	CbGpPWpGaD
Tramadol—HTR2C—Monoamine GPCRs—HTR2A—conduct disorder	0.000456	0.0208	CbGpPWpGaD
Tramadol—OPRD1—brain—conduct disorder	0.000438	0.0831	CbGeAlD
Tramadol—OPRK1—brain—conduct disorder	0.00042	0.0796	CbGeAlD
Tramadol—CHRM3—Monoamine GPCRs—HTR2A—conduct disorder	0.000393	0.0179	CbGpPWpGaD
Tramadol—HTR2C—Amine ligand-binding receptors—HTR2A—conduct disorder	0.000383	0.0175	CbGpPWpGaD
Tramadol—CHRM3—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00033	0.0151	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000324	0.0148	CbGpPWpGaD
Tramadol—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.000319	0.0146	CbGpPWpGaD
Tramadol—CYP3A4—Estrogen metabolism—COMT—conduct disorder	0.000308	0.0141	CbGpPWpGaD
Tramadol—OPRM1—brain—conduct disorder	0.000299	0.0566	CbGeAlD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000284	0.013	CbGpPWpGaD
Tramadol—SLC6A2—NRF2 pathway—SLC6A4—conduct disorder	0.000281	0.0128	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Other—DRD4—conduct disorder	0.000267	0.0122	CbGpPWpGaD
Tramadol—HTR2C—brain—conduct disorder	0.000262	0.0497	CbGeAlD
Tramadol—CHRM3—Regulation of Actin Cytoskeleton—WASF1—conduct disorder	0.000258	0.0118	CbGpPWpGaD
Tramadol—SLC6A4—brain—conduct disorder	0.000248	0.0471	CbGeAlD
Tramadol—OPRD1—GPCR ligand binding—CGA—conduct disorder	0.000247	0.0113	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00024	0.011	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—DRD4—conduct disorder	0.000238	0.0109	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—MAOA—conduct disorder	0.000233	0.0106	CbGpPWpGaD
Tramadol—OPRD1—G alpha (i) signalling events—DRD4—conduct disorder	0.000228	0.0104	CbGpPWpGaD
Tramadol—CHRM3—brain—conduct disorder	0.000221	0.042	CbGeAlD
Tramadol—SLC6A2—brain—conduct disorder	0.000219	0.0415	CbGeAlD
Tramadol—OPRK1—GPCR ligand binding—CGA—conduct disorder	0.000216	0.00989	CbGpPWpGaD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000212	0.00968	CbGpPWpGaD
Tramadol—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000208	0.00951	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000206	0.00943	CbGpPWpGaD
Tramadol—OPRK1—G alpha (i) signalling events—DRD4—conduct disorder	0.0002	0.00915	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—HTR2A—conduct disorder	0.00019	0.00867	CbGpPWpGaD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000186	0.00849	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—CGA—conduct disorder	0.000183	0.00836	CbGpPWpGaD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000182	0.0083	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.000178	0.00812	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Other—HTR2A—conduct disorder	0.000174	0.00797	CbGpPWpGaD
Tramadol—OPRM1—G alpha (i) signalling events—DRD4—conduct disorder	0.000169	0.00773	CbGpPWpGaD
Tramadol—CYP2B6—brain—conduct disorder	0.000161	0.0306	CbGeAlD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000159	0.00727	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—CGA—conduct disorder	0.000157	0.00718	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000157	0.00718	CbGpPWpGaD
Tramadol—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.000145	0.00661	CbGpPWpGaD
Tramadol—SLC6A2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.000141	0.00647	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—CGA—conduct disorder	0.000139	0.00637	CbGpPWpGaD
Tramadol—OPRD1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000138	0.00632	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—DRD4—conduct disorder	0.000138	0.00632	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—CGA—conduct disorder	0.000135	0.00618	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000135	0.00616	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000135	0.00615	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—CGA—conduct disorder	0.000127	0.00579	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—CGA—conduct disorder	0.000122	0.00559	CbGpPWpGaD
Tramadol—OPRK1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000121	0.00554	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—DRD4—conduct disorder	0.000121	0.00554	CbGpPWpGaD
Tramadol—CYP2D6—brain—conduct disorder	0.00012	0.0227	CbGeAlD
Tramadol—OPRD1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000118	0.00541	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.000116	0.00531	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.000116	0.00528	CbGpPWpGaD
Tramadol—HTR2C—G alpha (q) signalling events—HTR2A—conduct disorder	0.000114	0.0052	CbGpPWpGaD
Tramadol—CYP2B6—Biological oxidations—COMT—conduct disorder	0.000111	0.00509	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—CGA—conduct disorder	0.000111	0.00508	CbGpPWpGaD
Tramadol—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.000111	0.00505	CbGpPWpGaD
Tramadol—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00011	0.00502	CbGpPWpGaD
Tramadol—OPRK1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.000104	0.00475	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—CGA—conduct disorder	0.000103	0.00472	CbGpPWpGaD
Tramadol—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.000102	0.00468	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—DRD4—conduct disorder	0.000102	0.00468	CbGpPWpGaD
Tramadol—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.000102	0.00465	CbGpPWpGaD
Tramadol—SLC6A4—SIDS Susceptibility Pathways—EP300—conduct disorder	0.000101	0.0046	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	9.95e-05	0.00455	CbGpPWpGaD
Tramadol—CHRM3—G alpha (q) signalling events—HTR2A—conduct disorder	9.8e-05	0.00448	CbGpPWpGaD
Tramadol—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	9.46e-05	0.00432	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—CGA—conduct disorder	9.39e-05	0.00429	CbGpPWpGaD
Tramadol—OPRD1—GPCR ligand binding—HTR2A—conduct disorder	9.02e-05	0.00412	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—CGA—conduct disorder	8.88e-05	0.00406	CbGpPWpGaD
Tramadol—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	8.8e-05	0.00402	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—DRD4—conduct disorder	8.8e-05	0.00402	CbGpPWpGaD
Tramadol—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	8.78e-05	0.00401	CbGpPWpGaD
Tramadol—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	8.76e-05	0.00401	CbGpPWpGaD
Tramadol—SLC6A4—Circadian rythm related genes—EP300—conduct disorder	8.21e-05	0.00375	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—CGA—conduct disorder	8.06e-05	0.00368	CbGpPWpGaD
Tramadol—OPRK1—GPCR ligand binding—HTR2A—conduct disorder	7.91e-05	0.00361	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—DRD4—conduct disorder	7.81e-05	0.00357	CbGpPWpGaD
Tramadol—CYP2D6—Biological oxidations—COMT—conduct disorder	7.74e-05	0.00354	CbGpPWpGaD
Tramadol—CYP2D6—Biological oxidations—MAOA—conduct disorder	7.68e-05	0.00351	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—CGA—conduct disorder	7.64e-05	0.00349	CbGpPWpGaD
Tramadol—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	7.63e-05	0.00349	CbGpPWpGaD
Tramadol—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	7.57e-05	0.00346	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—DRD4—conduct disorder	7.57e-05	0.00346	CbGpPWpGaD
Tramadol—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	7.54e-05	0.00344	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—CGA—conduct disorder	7.48e-05	0.00342	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—DRD4—conduct disorder	7.09e-05	0.00324	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—CGA—conduct disorder	6.94e-05	0.00317	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—DRD4—conduct disorder	6.85e-05	0.00313	CbGpPWpGaD
Tramadol—OPRM1—GPCR ligand binding—HTR2A—conduct disorder	6.68e-05	0.00305	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—CGA—conduct disorder	6.56e-05	0.003	CbGpPWpGaD
Tramadol—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	6.49e-05	0.00297	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—DRD4—conduct disorder	6.22e-05	0.00284	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—WASF1—conduct disorder	6e-05	0.00274	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—DRD4—conduct disorder	5.79e-05	0.00265	CbGpPWpGaD
Tramadol—HTR2C—GPCR ligand binding—HTR2A—conduct disorder	5.74e-05	0.00262	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—CGA—conduct disorder	5.55e-05	0.00253	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—WASF1—conduct disorder	5.26e-05	0.0024	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—DRD4—conduct disorder	5.26e-05	0.0024	CbGpPWpGaD
Tramadol—OPRD1—GPCR downstream signaling—HTR2A—conduct disorder	5.1e-05	0.00233	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—COMT—conduct disorder	5.06e-05	0.00231	CbGpPWpGaD
Tramadol—CYP3A4—Biological oxidations—MAOA—conduct disorder	5.02e-05	0.0023	CbGpPWpGaD
Tramadol—CYP3A4—Metapathway biotransformation—COMT—conduct disorder	4.99e-05	0.00228	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—DRD4—conduct disorder	4.97e-05	0.00227	CbGpPWpGaD
Tramadol—CHRM3—GPCR ligand binding—HTR2A—conduct disorder	4.94e-05	0.00226	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—CGA—conduct disorder	4.9e-05	0.00224	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—CGA—conduct disorder	4.76e-05	0.00218	CbGpPWpGaD
Tramadol—OPRD1—Signaling by GPCR—HTR2A—conduct disorder	4.63e-05	0.00212	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—DRD4—conduct disorder	4.51e-05	0.00206	CbGpPWpGaD
Tramadol—OPRK1—GPCR downstream signaling—HTR2A—conduct disorder	4.47e-05	0.00204	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—WASF1—conduct disorder	4.44e-05	0.00203	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—DRD4—conduct disorder	4.28e-05	0.00196	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—CGA—conduct disorder	4.22e-05	0.00193	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—DRD4—conduct disorder	4.19e-05	0.00192	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—CGA—conduct disorder	4.1e-05	0.00187	CbGpPWpGaD
Tramadol—OPRK1—Signaling by GPCR—HTR2A—conduct disorder	4.06e-05	0.00185	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—DRD4—conduct disorder	3.89e-05	0.00178	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—WASF1—conduct disorder	3.82e-05	0.00174	CbGpPWpGaD
Tramadol—OPRM1—GPCR downstream signaling—HTR2A—conduct disorder	3.78e-05	0.00173	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—DRD4—conduct disorder	3.67e-05	0.00168	CbGpPWpGaD
Tramadol—OPRM1—Signaling by GPCR—HTR2A—conduct disorder	3.43e-05	0.00157	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—WASF1—conduct disorder	3.29e-05	0.0015	CbGpPWpGaD
Tramadol—HTR2C—GPCR downstream signaling—HTR2A—conduct disorder	3.24e-05	0.00148	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—DRD4—conduct disorder	3.11e-05	0.00142	CbGpPWpGaD
Tramadol—HTR2C—Signaling by GPCR—HTR2A—conduct disorder	2.95e-05	0.00135	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—CGA—conduct disorder	2.93e-05	0.00134	CbGpPWpGaD
Tramadol—CHRM3—GPCR downstream signaling—HTR2A—conduct disorder	2.79e-05	0.00128	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—HTR2A—conduct disorder	2.73e-05	0.00125	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—DRD4—conduct disorder	2.67e-05	0.00122	CbGpPWpGaD
Tramadol—CHRM3—Signaling by GPCR—HTR2A—conduct disorder	2.54e-05	0.00116	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—HTR2A—conduct disorder	2.4e-05	0.0011	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—DRD4—conduct disorder	2.3e-05	0.00105	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—COMT—conduct disorder	2.21e-05	0.00101	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—MAOA—conduct disorder	2.2e-05	0.001	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—HTR2A—conduct disorder	2.03e-05	0.000926	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—CGA—conduct disorder	1.92e-05	0.000876	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—COMT—conduct disorder	1.9e-05	0.00087	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—MAOA—conduct disorder	1.89e-05	0.000864	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—HTR2A—conduct disorder	1.74e-05	0.000795	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—HTR2A—conduct disorder	1.5e-05	0.000685	CbGpPWpGaD
Tramadol—OPRD1—Signaling Pathways—EP300—conduct disorder	1.45e-05	0.000662	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—COMT—conduct disorder	1.32e-05	0.000605	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—MAOA—conduct disorder	1.31e-05	0.000601	CbGpPWpGaD
Tramadol—OPRK1—Signaling Pathways—EP300—conduct disorder	1.27e-05	0.00058	CbGpPWpGaD
Tramadol—OPRM1—Signaling Pathways—EP300—conduct disorder	1.07e-05	0.000491	CbGpPWpGaD
Tramadol—CHRM3—Metabolism—EP300—conduct disorder	9.49e-06	0.000434	CbGpPWpGaD
Tramadol—HTR2C—Signaling Pathways—EP300—conduct disorder	9.22e-06	0.000421	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—COMT—conduct disorder	8.65e-06	0.000395	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—MAOA—conduct disorder	8.59e-06	0.000393	CbGpPWpGaD
Tramadol—CYP2B6—Metabolism—EP300—conduct disorder	8.17e-06	0.000373	CbGpPWpGaD
Tramadol—CHRM3—Signaling Pathways—EP300—conduct disorder	7.94e-06	0.000363	CbGpPWpGaD
Tramadol—CYP2D6—Metabolism—EP300—conduct disorder	5.68e-06	0.000259	CbGpPWpGaD
Tramadol—CYP3A4—Metabolism—EP300—conduct disorder	3.71e-06	0.00017	CbGpPWpGaD
